Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference

Rhea-AI Summary

Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12th at 9:00 AM EDT.

The company, a pioneer in the over-the-counter (OTC) self-care market, has over a century of experience providing health and wellness solutions in North America and Europe. Perrigo's business model combines store brand private label offerings with leading brands including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

DUBLIN, July 29, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Canaccord Genuity 45^th Annual Growth Conference, on Tuesday, August 12^th at 9:00 AM EDT. 

Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

About Perrigo  

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements 

This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord Genuity 45^th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-present-at-the-canaccord-genuity-45th-annual-growth-conference-302515980.html

SOURCE Perrigo Company plc

FAQ

When is Perrigo (PRGO) presenting at the Canaccord Genuity Growth Conference 2025?

Perrigo will present at the conference on Tuesday, August 12th, 2025 at 9:00 AM EDT.

Who will represent Perrigo at the Canaccord Genuity Conference?

President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will represent Perrigo at the conference.

How can investors access Perrigo's presentation at the Canaccord conference?

Investors can access the webcast through Perrigo's website at http://perrigo.investorroom.com/events-webcasts.

What are Perrigo's main consumer brands?

Perrigo's leading brands include Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.